Back to Journals » Drug, Healthcare and Patient Safety » Volume 7
Original Research
Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
15,705 | Dovepress* | 14,015+ | 1,437 | 15,452 | |
PubMed Central* | 1,690 | 312 | 2,002 | ||
Totals | 15,705 | 1,749 | 17,454 | ||
*Since 15 December 2015 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
18 | 0 | 0 | 0 | 8 | 10 |
View citations on PubMed Central and Google Scholar